Brahm Goldstein

Dr. Goldstein is the Vice President, Research and Development, Hematology at CSL Behring. He has held leadership roles at several biotechnology and pharmaceutical companies including Baxter, Shire, Novo Nordisk, and Ikaria. He was formerly the Chief of Pediatric Critical Care at Oregon Health & Science University where his research focused on pediatric vital sign monitoring.